Abcepta

Abcepta is a global biotechnology company based in San Diego, California, with offices around the world. Abcepta is a leading manufacturer of primary antibodies with more than a decade of experience. Meeting the ever changing demands of research and drug discovery through a thoughtful target selection process and strengthened validation-standards.

Company highlights:

• Most antibodies are produced in-house to ensure specificity, affinity, and reproducibility.
• Over 1,000 new antibodies are released per year with an emphasis on autophagy, stem cells, and neurodegeneration and more.
• Striving for proteome-wide antibody coverage.
• Featuring our “Crown” line of premium antibodies and offering evaluation size vials for more than 10,000 products.

In addition, Abcepta offers the highest quality services including custom antibody development, custom peptide synthesis and custom protein expression. Synthesis of difficult peptides, including long peptides, is a core competency of Abcepta. High quality, rapid turnaround and personal support for all Abcepta services are guaranteed.